Loading...
Paclitaxel/sirolimus combination coated drug-eluting stent: In vitro and in vivo drug release studies
Paclitaxel and sirolimus are the two major drugs for the treatment of coronary arterial disease in current drug eluting stents. The two drugs can effectively inhibit the in-stent restenosis through their independent pathways and show synergistic effect in preventing tumor tissue growth. We hypothesi...
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2010
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3008332/ https://ncbi.nlm.nih.gov/pubmed/21126843 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpba.2010.10.027 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|